Chemed Corporation

NYSE CHE

Chemed Corporation EBIT for the Trailing 12 Months (TTM) ending September 30, 2024: USD 377.85 M

Chemed Corporation EBIT is USD 377.85 M for the Trailing 12 Months (TTM) ending September 30, 2024, a 17.47% change year over year. EBIT means earnings before interest and taxes, it is calculated as operating income plus non-operating income.

Chemed Corporation EBIT for the Trailing 12 Months (TTM) ending September 30, 2023 was USD 321.64 M, a -8.31% change year over year.
Chemed Corporation EBIT for the Trailing 12 Months (TTM) ending September 30, 2022 was USD 350.78 M, a -12.68% change year over year.
Chemed Corporation EBIT for the Trailing 12 Months (TTM) ending September 30, 2021 was USD 401.72 M, a 19.06% change year over year.
Chemed Corporation EBIT for the Trailing 12 Months (TTM) ending September 30, 2020 was USD 337.41 M, a 35.29% change year over year.

Key data

Date	EBIT	EBITDA	Net Income	EPS (Diluted)

NYSE: CHE

Chemed Corporation

CEO	Mr. Kevin J. McNamara
IPO Date	May 3, 1973
Location	United States
Headquarters	255 East Fifth Street
Employees	15,087
Sector	Health Care
Industries Senior Care Telehealth

Description

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in two segments, VITAS and Roto-Rooter. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company was incorporated in 1970 and is headquartered in Cincinnati, Ohio.

Key trends

Past 5 years